Risk of Nonmelanoma Skin Cancers and Parkinson's Disease-Meta-Analysis and Systematic Review

被引:6
作者
Krasowska, Danuta [1 ]
Gerkowicz, Agnieszka [1 ]
Mlak, Radoslaw [2 ]
Leziak, Milena [2 ]
Malecka-Massalska, Teresa [2 ]
Krasowska, Dorota [1 ]
机构
[1] Med Univ Lublin, Dept Dermatol Venerol & Pediat Dermatol, Poland 11 Staszica St, PL-20081 Lublin, Poland
[2] Med Univ Lublin, Dept Human Physiol, Poland 11 Radziwillowska St, PL-20080 Lublin, Poland
关键词
Parkinson disease; nonmelanoma skin cancers; meta-analysis; systematic review;
D O I
10.3390/cancers13040587
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Non-melanoma skin cancers (NMSCs) are the most common cancers among fair-skinned people. It is estimated that 2-3 million new cases of NMSCs are diagnosed globally each year. The risk of development increases with age, just like in the case of Parkinson Disease. Due to the general aging of the population and substantially high medical costs of NMSC therapy, NMSCs and Parkinson's disease (PD) are becoming an increasing health problem. In this paper, we conduct a meta-analysis and systematic review to evaluate the NMSC risk among patients with PD. This study is the first to focus on the effect of different epidemiologic aspects of NMSCs and PD in detail. Patients with Parkinson's disease (PD) have an increased risk of melanoma compared with the general population. Considering that Nonmelanoma Skin Cancers (NMSCs) share similar risk factors with melanoma, there is a need to understand a possible connection between PD and NMSCs. The aim of the study was the evaluation of NMSC risk among PD patients via meta-analysis and systematic review. A comprehensive search of PubMed, Scopus, and Web of Science databases was conducted, including studies from January 2000 to April 2020. We identified 16 eligible studies including 140291 PD patients. Upon statistical analysis, a significantly higher risk of developing NMSCs in PD patients was found compared with the control group (odds ratio (OR) = 1.25, 95% CI: 1.17-1.33; p < 0.0001). Among all NMSCs, the risk of developing basal cell carcinoma in PD patients was significantly higher (OR = 1.30, 95% confidence interval (CI): 1.15-1.47; p < 0.0001), contrary to squamous cell carcinoma. Further analysis revealed a significantly higher risk of developing NMSCs in patients with previously diagnosed PD (OR = 1.26, 95% CI: 1.19-1.33; p < 0.0001). Our data suggest the necessity for regular skin examination of PD patients, though further studies are required to explore the mechanisms forming this relationship.
引用
收藏
页码:1 / 13
页数:13
相关论文
共 40 条
  • [1] Apalla Z., 2017, DERMATOL PRACT CONCE, V7, P1, DOI 10.5826/dpc.0702a01
  • [2] The epidemiology of Parkinson's disease: risk factors and prevention
    Ascherio, Alberto
    Schwarzschild, Michael A.
    [J]. LANCET NEUROLOGY, 2016, 15 (12) : 1255 - 1270
  • [3] The role of EGFR overexpression on the recurrence of basal cell carcinomas with positive surgical margins
    Avci, Cigir Biray
    Kaya, Isa
    Ozturk, Arin
    Ay, Neslihan Pinar Ozates
    Sezgin, Baha
    Kurt, Cansu Caliskan
    Akyildiz, Nurullah Serdar
    Bozan, Aykut
    Yaman, Banu
    Akalin, Taner
    Apaydin, Fazil
    [J]. GENE, 2019, 687 : 35 - 38
  • [4] Parkinson's disease and cancer risk: a systematic review and meta-analysis
    Bajaj, Archna
    Driver, Jane A.
    Schernhammer, Eva S.
    [J]. CANCER CAUSES & CONTROL, 2010, 21 (05) : 697 - 707
  • [5] Parkinson's Disease and Melanoma: Co-Occurrence and Mechanisms
    Bose, Anindita
    Petsko, Gregory A.
    Eliezer, David
    [J]. JOURNAL OF PARKINSONS DISEASE, 2018, 8 (03) : 385 - 398
  • [6] Parkinson Disease and Melanoma: Confirming and Reexamining an Association
    Dalvin, Lauren A.
    Damento, Gena M.
    Yawn, Barbara P.
    Abbott, Barbara A.
    Hodge, David O.
    Pulido, Jose S.
    [J]. MAYO CLINIC PROCEEDINGS, 2017, 92 (07) : 1070 - 1079
  • [7] Prospective case-control study of nonfatal cancer preceding the diagnosis of Parkinson's disease
    Driver, Jane A.
    Kurth, Tobias
    Buring, Julie E.
    Gaziano, J. Michael
    Logroscino, Giancarlo
    [J]. CANCER CAUSES & CONTROL, 2007, 18 (07) : 705 - 711
  • [8] Risk of cancer after the diagnosis of Parkinson's disease: A historical cohort study
    Elbaz, A
    Peterson, BJ
    Bower, JH
    Yang, P
    Maraganore, DM
    McDonnell, SK
    Ahlskog, JE
    Rocca, WA
    [J]. MOVEMENT DISORDERS, 2005, 20 (06) : 719 - 725
  • [9] Nonfatal cancer preceding Parkinson's disease: A case-control study
    Elbaz, A
    Peterson, BJ
    Yang, P
    Van Gerpen, JA
    Bower, JH
    Maraganore, DM
    McDonnell, SK
    Ahlskog, JE
    Rocca, WA
    [J]. EPIDEMIOLOGY, 2002, 13 (02) : 157 - 164
  • [10] Basal cell carcinoma, squamous cell carcinoma and melanoma of the head and face
    Feller, L.
    Khammissa, R. A. G.
    Kramer, B.
    Altini, M.
    Lemmer, J.
    [J]. HEAD & FACE MEDICINE, 2016, 12